Daily Independent on MSN2 小时
Doctor Needs N17m To Fight Tumour
Practising Optometrist, Dr Lynda Lucky, is fight­ing the battle of her life as she confronts colon cancer. The ebullient eye doctor frantically needs Seventeen mil­lion Naira (N17m) to fund cancer ...
Symptoms that are sometimes diagnosed as part of dementia might actually be related to a treatable liver condition, according ...
Devonian Health Group Inc. ("Devonian" or the "Company") (TSXV: GSD; OTCQB: DVHGF), a clinical stage corporation focused on ...
Delcath Systems, Inc. ("Delcath" or the "Company"), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, today announced an update to the ...
Furin is identified as the key enzyme responsible for cleaving the apelin precursor. Inhibiting this cleavage could serve as ...
Discover why combining simvastatin and rifaximin does not offer a clinically meaningful advantage in preventing severe ...
Researchers found that high fructose intake, especially from processed foods, is linked to metabolic dysfunction-associated ...
Solid Biosciences (SLDB) announced initial data from the Phase 1/2 INSPIRE DUCHENNE trial evaluating SGT-003, a next-generation gene therapy ...
Targeted Oncology provides news, videos, and reviews on the rapidly evolving world of targeted therapies and immunotherapy ...
The FDA has approved Emblaveo with metronidazole for patients with complicated intra-abdominal infections and limited options.
AVEO Oncology, an LG Chem company ("AVEO"), is a biopharmaceutical company that is trying to provide differentiated solutions to improve cancer patients lives, presented two posters during the ...
The most common benign liver tumors, hemangiomas, start in cells lining blood vessels. Most liver hemangiomas don’t cause symptoms and don’t need treatment. But if they bleed or cause other problems, ...